Loading...
Femasys Inc (FEMY) is not a strong buy for a beginner, long-term investor at this time. The stock shows bearish technical indicators, weak financial performance, and lacks significant positive catalysts or trading signals. While the analyst rating is positive with a high price target, the company's current financials and technical trends do not support immediate investment.
The technical indicators for FEMY are bearish. The MACD is negative and expanding downward, the RSI is neutral at 32.081, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.481, with resistance levels at 0.549 and 0.57.
Laidlaw analyst initiated coverage with a Buy rating and a $6.50 price target, citing large market opportunities for FemaSeed and FemBloc.
The stock has shown a consistent decline in price (-2.91% regular market change, -2.08% post-market change). Financial performance is weak, with a significant drop in net income (-22.45% YoY) and EPS (-58.33% YoY). Gross margin also declined by 7.50%.
In Q3 2025, revenue increased by 31.44% YoY to $729,394. However, net income dropped by 22.45% YoY to -$4,194,821, EPS fell by 58.33% YoY to -0.1, and gross margin declined to 47.97%, down 7.50% YoY. Overall, the financials show growth in revenue but worsening profitability metrics.
Laidlaw analyst initiated a Buy rating with a $6.50 price target, highlighting potential in FemaSeed and FemBloc. However, no other analyst ratings or updates are available.